# Hildred Capital Partners

> Hildred Capital Partners is a VC fund backing Health Care and Pharmaceutical. See 9 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 9
- Last investment: May 2023
- Lead investor: 44%
- Fund size: $363M
- Last fund: Feb 2022
- Last updated: Aug 2026
- Website: http://hildredpartners.com/

Hildred Capital Partners is a VC fund in New York focused on Health Care and Pharmaceutical. Hildred Capital Partners, LLC is a family investment firm that invests in a broad range of securities, including equity and debt, across geographies and sectors, on both an active and passively managed basis. Hildred has a particular interest in private equity, including situations where the principals can apply their extensive managementexperience to help a company reach its full potential.

## Contacts

5 contacts available for Hildred Capital Partners. Shizune tracks 2 team members at Hildred Capital Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/hildred-capital-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 6 | 67% |
| Pharmaceutical | 3 | 33% |
| Manufacturing | 2 | 22% |
| Mobile | 1 | 11% |
| Consumer | 1 | 11% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 4 | 44% |
| Series C | 1 | 11% |
| Series E | 1 | 11% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David F. Solomon | Partner | 4 | — |
| Anthony Gerrits | Chief Investment Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AleraCare Holdings | AleraCare Holdings is a provider of both home and community-based healthcare and pharmacy services for high-need and medically complex populations. |  | Private Equity | May 02, 2023 |  |
| AleraCare Holdings | AleraCare Holdings is a provider of both home and community-based healthcare and pharmacy services for high-need and medically complex populations. |  | Private Equity | May 02, 2023 |  |
| Healthcare.com | HealthCare is an online health insurance company providing a data-driven shopping platform that helps American consumers enroll in individual health insurance and Medicare plans. HealthCare.com also develops and markets a portfolio of proprietary, direct-to-consumer health insurance, and supplemental insurance products under the name Pivot Health.Founded in 2014, the company is headquartered in New York City and is backed by PeopleFund and individual investors including current and former executives of Booking.com and Priceline. HealthCare.com is a 5-time honoree of the Inc. 5000 list of America’s fastest-growing companies. | $31.5M | Series C | Feb 08, 2022 |  |
| Binx Health | Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer | $104M | Series E | May 27, 2021 |  |
| Dermcare Management | DermCare Management assists dermatologists in maintaining strong patient loyalty by partnering with their management expertise. Our philosophy is to create a team-oriented environment in healthcare by providing the tools needed to achieve practice growth while improving the quality of care that has led to the success of our partner practice. |  | Private Equity | Oct 19, 2019 |  |
| Crown Laboratories | Crown Laboratories, Inc. is a fully integrated specialty pharmaceutical company offering Consumer Healthcare Products, Prescription Products, and Contract Development and Manufacturing Services. |  | Private Equity | May 03, 2019 |  |
| Crown Laboratories | Crown Laboratories, Inc. is a fully integrated specialty pharmaceutical company offering Consumer Healthcare Products, Prescription Products, and Contract Development and Manufacturing Services. |  | Private Equity | Oct 30, 2017 |  |
| Pharmaceutics International | Pii is a science-driven contract development and manufacturing company providing dosage form development and cGMP manufacturing services to the global pharmaceutical industry. Pii’s vision is to be the benchmark in pharmaceutical product development outsourcing. They strive to do this with their mix of broad scientific capabilities, seasonedtalent, attentive customer service and an exceptional quality record. By providing extensive technical capabilities and a high level of customer service, Pii continues to grow with new and repeat business. This has resulted in a balanced client base of major multinational and virtual pharmaceutical companies located across the globe. | $93M | Private Equity | Sep 06, 2016 |  |
| Pharmaceutics International | Pii is a science-driven contract development and manufacturing company providing dosage form development and cGMP manufacturing services to the global pharmaceutical industry. Pii’s vision is to be the benchmark in pharmaceutical product development outsourcing. They strive to do this with their mix of broad scientific capabilities, seasonedtalent, attentive customer service and an exceptional quality record. By providing extensive technical capabilities and a high level of customer service, Pii continues to grow with new and repeat business. This has resulted in a balanced client base of major multinational and virtual pharmaceutical companies located across the globe. | $93M | Private Equity | Sep 06, 2016 |  |

9 of 9 investments shown.

## Co-investors
- [Athyrium Capital Management LP](https://shizune.co/investors/profile/athyrium-capital-management) — VC Fund, 2 deals together
- [Pharmascience](https://shizune.co/investors/profile/pharmascience) — VC Fund, 2 deals together
- [Signet Healthcare Partners](https://shizune.co/investors/profile/signet-healthcare-partners) — VC Fund, 2 deals together
- [Alta Life Sciences](https://shizune.co/investors/profile/alta-life-sciences) — VC Fund, 1 deal together
- [ArrowMark Partners](https://shizune.co/investors/profile/arrowpoint-partners) — VC Fund, 1 deal together
- [Greenspring Associates](https://shizune.co/investors/profile/greenspring-associates) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does Hildred Capital Partners invest in?

Hildred Capital Partners invests primarily in Health Care, Pharmaceutical and Manufacturing startups, most often at Private Equity and Series C stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Hildred Capital Partners?

Public channels for Hildred Capital Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Hildred Capital Partners?

The team at Hildred Capital Partners includes David F. Solomon (Partner) and Anthony Gerrits (Chief Investment Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co